TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17447668

Group type: EXPERIMENTAL
Intervention: High-to-low workload condition
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Low-to-high workload condition
Number of subjects: 198
Study: 15043687

Group type: EXPERIMENTAL
Intervention: 5 mg melatonin for 1 week
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 12148426

Group type: EXPERIMENTAL
Intervention: Zipper device for skin closure
Number of subjects: 610

Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 610
Study: 9497182

Group type: EXPERIMENTAL
Intervention: 10% carbohydrate solution (CHO; 170 +/- 6 g glucose)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 10% carbohydrate electrolyte with 5% MCT solution (CHO + MCT; 85 +/- 3 g MCT)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 5% MCT solution
Number of subjects: 7

Group type: COMPARATOR
Intervention: artificially colored and flavored water (placebo)
Number of subjects: 7
Study: 8803911

Group type: EXPERIMENTAL
Intervention: Combination therapy including hydroxychloroquine, methotrexate, and sulphasalazine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination therapy
Number of subjects: 0
Study: 2317424

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 8% glucose
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 0.83% glucose
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 0.33% glucose
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with any glucose concentration
Number of subjects: 30
Study: 6988172

Group type: EXPERIMENTAL
Intervention: Feprazone (800 mg daily for 2 days, then 600 mg daily for up to 8 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Phenylbutazone (800 mg daily for 2 days, then 600 mg daily for up to 8 days)
Number of subjects: 24
Study: 30630753

Group type: EXPERIMENTAL
Intervention: Perturbation-Based Balance Training (PBT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Traditional Balance Training (Control)
Number of subjects: 16
Study: 28698320

Group type: EXPERIMENTAL
Intervention: SPACE for COPD(C) self‐management programme delivered over 5 months (six sessions, group-based)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 25780062

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Exercise plus chemotherapy (cyclophosphamide)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sedentary control
Number of subjects: 11
Study: 24552972

Group type: EXPERIMENTAL
Intervention: Virtual body swapping with mental rehearsal (VBS)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Watching movement only
Number of subjects: 39

Group type: COMPARATOR
Intervention: Mental rehearsal only
Number of subjects: 39
Study: 23304686

Group type: EXPERIMENTAL
Intervention: Light-activated disinfection (LAD) (FotoSan)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no LAD)
Number of subjects: 80
Study: 19892713

Group type: EXPERIMENTAL
Intervention: Echocardiography
Number of subjects: 26

Group type: COMPARATOR
Intervention: QuickOpt
Number of subjects: 26
Study: 17341565

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (40 mg every second day)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Estradiol valerate (2 mg daily)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Combination of testosterone and estradiol
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control (Testosterone alone)
Number of subjects: 63
Study: 15761754

Group type: EXPERIMENTAL
Intervention: High concentration of enalaprilat (>50 ng/ml)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low concentration of enalaprilat (<10 ng/ml)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High concentration of enalaprilat
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low concentration of enalaprilat
Number of subjects: 40
Study: 12082361

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) 5 mg/day
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Micronized, oil-suspended progesterone 200 mg/day
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Combined progestogens (MPA and progesterone)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 10207208

Group type: EXPERIMENTAL
Intervention: Vocal cord paresis (VCP) in acute ischemic stroke patients
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Dysphonia correlation
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Resolution of VCP
Number of subjects: 54
Study: 8701750

Group type: EXPERIMENTAL
Intervention: Huperzine-A (Hup) 0.2 mg (4 tablets) orally, twice daily for 8 weeks
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo (4 tablets) orally, twice daily for 8 weeks
Number of subjects: 103
Study: 2140961

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF) infusion (1.95 pmol/min per kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Captopril (25 mg, administered orally) with physiological saline (placebo)
Number of subjects: 0
Study: 158752

Group type: EXPERIMENTAL
Intervention: Traditional acupuncture
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 77
Study: 31289040

Group type: EXPERIMENTAL
Intervention: Nivolumab and ipilimumab (peri-operative immunotherapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 27988849

Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy (NPWT) and antibiotic treatment after surgical debridement
Number of subjects: 115
Study: 25474553

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (60 mg daily)
Number of subjects: 523

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 523
Study: 23894865

Group type: EXPERIMENTAL
Intervention: Wiping 70% isopropyl alcohol at the site of venipuncture
Number of subjects: 52

Group type: COMPARATOR
Intervention: Not wiping 70% isopropyl alcohol at the site of venipuncture
Number of subjects: 52
Study: 21646599

Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg once daily (N=65)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Metoprolol 95 mg once daily (N=63)
Number of subjects: 128
Study: 19344465

Group type: EXPERIMENTAL
Intervention: Supervised aerobic and strength training (SET)
Number of subjects: 43

Group type: COMPARATOR
Intervention: No-training (NT)
Number of subjects: 43
Study: 16410677

Group type: EXPERIMENTAL
Intervention: Cabergoline (1 mg/day) + Clarithromycin (400 mg/day) for 6 days
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Cabergoline (stable doses) + Clarithromycin (400 mg/day) for 6 days
Number of subjects: 17

Group type: COMPARATOR
Intervention: Cabergoline (1 mg/day) for 6 days
Number of subjects: 17
Study: 14977306

Group type: EXPERIMENTAL
Intervention: AH Plus sealer with smear layer
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Apexit sealer with smear layer
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Roth 811 sealer with smear layer
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: AH Plus sealer without smear layer
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Apexit sealer without smear layer
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Roth 811 sealer without smear layer
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group A (smear layer intact)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group B (smear layer removed)
Number of subjects: 64
Study: 11306204

Group type: EXPERIMENTAL
Intervention: Oral conjugated estrogens 0.625 mg/day for 28 days plus MAP 10 mg/day for the last 14 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Transdermal estradiol 50 mcg every 7 days for 28 days plus MAP 10 mg/day from 15th to 28th day
Number of subjects: 50
Study: 9272341

Group type: EXPERIMENTAL
Intervention: DTaP vaccine
Number of subjects: 10771

Group type: EXPERIMENTAL
Intervention: DTP vaccine
Number of subjects: 10771

Group type: EXPERIMENTAL
Intervention: DT vaccine
Number of subjects: 10771
Study: 9217687

Group type: EXPERIMENTAL
Intervention: Euglycaemia-hypoglycaemia-euglycaemia treatment order
Number of subjects: 0

Group type: COMPARATOR
Intervention: Euglycaemia-placebo(euglycaemia)-euglycaemia treatment sequence
Number of subjects: 0
Study: 2547305

Group type: EXPERIMENTAL
Intervention: vindesine/cis‐platin
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: etoposide/cis‐platin
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: vindesine/etoposide/cis‐platin
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: cis‐platin/vindesine/etoposide
Number of subjects: 152
Study: 973963

Group type: EXPERIMENTAL
Intervention: Diazepam (2.5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diazepam (5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amylobarbitone sodium (50 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amylobarbitone sodium (100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lactose (Control)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: All active drugs
Number of subjects: 12
Study: 31226412

Group type: EXPERIMENTAL
Intervention: Passive linkage with NCMS claims data
Number of subjects: 33948

Group type: COMPARATOR
Intervention: Active follow-up
Number of subjects: 33948
Study: 28830428

Group type: EXPERIMENTAL
Intervention: Synergy 1 (oligofructose-enriched inulin) 10 g daily
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 34
Study: 25253582

Group type: EXPERIMENTAL
Intervention: Olmesartan combined with a calcium channel blocker (CCB)
Number of subjects: 5141

Group type: COMPARATOR
Intervention: Olmesartan combined with a diuretic
Number of subjects: 5141
Study: 23675705

Group type: EXPERIMENTAL
Intervention: Social dancing (ballroom or folk dance)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Wait-listed control
Number of subjects: 450
Study: 21939829

Group type: EXPERIMENTAL
Intervention: Household income <$20,000
Number of subjects: 26160

Group type: EXPERIMENTAL
Intervention: Less than a high school education
Number of subjects: 26160

Group type: EXPERIMENTAL
Intervention: Lowest income levels
Number of subjects: 26160

Group type: EXPERIMENTAL
Intervention: Least amount of education
Number of subjects: 26160
Study: 19801053

Group type: EXPERIMENTAL
Intervention: Maximal strength training (STG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional rehabilitation (CRG)
Number of subjects: 24
Study: 16685296

Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix allograft (ADMA)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft (SCTG)
Number of subjects: 14
Study: 15385015

Group type: EXPERIMENTAL
Intervention: Remifentanil (0‐1 microg x kg(‐1) x min(‐1))
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fentanyl (30 microg x kg(‐1)) plus morphine (1 mg x kg(‐1))
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 11259471

Group type: EXPERIMENTAL
Intervention: Tamoxifen (adjuvant arm) for 5 years
Number of subjects: 1323

Group type: EXPERIMENTAL
Intervention: Tamoxifen (duration trial) continued indefinitely
Number of subjects: 1323

Group type: EXPERIMENTAL
Intervention: Tamoxifen (duration trial) stopped after 5 years
Number of subjects: 1323
Study: 9223734

Group type: EXPERIMENTAL
Intervention: Immediate zidovudine (ZVD) therapy
Number of subjects: 1749
Study: 8093681

Group type: EXPERIMENTAL
Intervention: modafinil
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study: 3072419

Group type: EXPERIMENTAL
Intervention: Ketanserin (80 mg daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30324834

Group type: EXPERIMENTAL
Intervention: letrozole with luteal support using vaginal dydrogesterone (n = 94)
Number of subjects: 186

Group type: COMPARATOR
Intervention: letrozole alone (n = 92)
Number of subjects: 186
Study: 28169927

Group type: EXPERIMENTAL
Intervention: Video recording and replaying system
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional training method
Number of subjects: 60
Study: 26526507

Group type: EXPERIMENTAL
Intervention: Ribavirin (5‐10mg/kg daily divided into 2 doses)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Local steroids
Number of subjects: 30
Study: 23612730

Group type: EXPERIMENTAL
Intervention: MediGuide Technology
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (conventional ablation)
Number of subjects: 24
Study: 21697629

Group type: EXPERIMENTAL
Intervention: Anterior pelvic tilt taping (APTT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No anterior pelvic tilt taping (no-APTT)
Number of subjects: 0
Study: 18094011

Group type: EXPERIMENTAL
Intervention: Pharmacist intervention focused on improving inhalation technique and medication adherence
Number of subjects: 201

Group type: COMPARATOR
Intervention: Usual pharmacist care
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Pharmacist intervention
Number of subjects: 201
Study: 16198027

Group type: EXPERIMENTAL
Intervention: HBV-ISS (0, 8 weeks)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Engerix-B (0, 8, 24 weeks)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: HBV-ISS
Number of subjects: 99
Study: 12974594

Group type: EXPERIMENTAL
Intervention: Propofol-alfentanil infusion
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Boluses of fentanyl with a propofol infusion
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Boluses of fentanyl and midazolam
Number of subjects: 88
Study: 11885172

Group type: EXPERIMENTAL
Intervention: Top Performance Group (TPG) implants
Number of subjects: 2900

Group type: EXPERIMENTAL
Intervention: Middle Performance Group (MPG) implants
Number of subjects: 2900

Group type: EXPERIMENTAL
Intervention: Lower Performance Group (LPG) implants
Number of subjects: 2900

Group type: EXPERIMENTAL
Intervention: HA-coated cylinder implants
Number of subjects: 2900

Group type: EXPERIMENTAL
Intervention: Commercially pure titanium screw implants
Number of subjects: 2900
Study: 8832445

Group type: EXPERIMENTAL
Intervention: 2 million KIU of aprotinin over 20 minutes
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 40
Study: 1349184

Group type: EXPERIMENTAL
Intervention: Removal of worms (treatment)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group (uninfected)
Number of subjects: 159
Study: 6146995

Group type: EXPERIMENTAL
Intervention: cis(Z)-clopenthixol decanoate
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: fluphenazine decanoate
Number of subjects: 8
Study: 31500466

Group type: EXPERIMENTAL
Intervention: High-dose aspirin treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable (placebo control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not applicable (survivors)
Number of subjects: 0
Study: 30324975

Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI) - 8 sessions, 10 min each at 11-12 °C
Number of subjects: 20

Group type: COMPARATOR
Intervention: No Cold Water Immersion (no-CWI) - control group
Number of subjects: 20
Study: 26284383

Group type: EXPERIMENTAL
Intervention: Group physical activity intervention for 6 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Group physical activity intervention
Number of subjects: 20
Study: 24280639

Group type: EXPERIMENTAL
Intervention: Training in emotion understanding (conversations on emotion understanding after reading illustrated scenarios)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (producing a drawing about the story)
Number of subjects: 110
Study: 22494796

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 20142601

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 299

Group type: COMPARATOR
Intervention: Healthy Controls
Number of subjects: 299
Study: 18568921

Group type: EXPERIMENTAL
Intervention: BodySense intervention program (3-month duration)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study: 16496604

Group type: EXPERIMENTAL
Intervention: HA Biocer implants
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 11868925

Group type: EXPERIMENTAL
Intervention: Locally collected, unpasteurized, unfiltered honey
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nationally collected, filtered, and pasteurized honey
Number of subjects: 36

Group type: COMPARATOR
Intervention: Corn syrup with synthetic honey flavoring (placebo)
Number of subjects: 36
Study: 10520795

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drug (AAD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD)
Number of subjects: 0
Study: 8616478

Group type: EXPERIMENTAL
Intervention: Sialic acid concentration in bronchoalveolar lavage fluid (BALF) in patients with interstitial pulmonary diseases
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Sialic acid concentration in BALF in patients with avian fanciers lung
Number of subjects: 187

Group type: COMPARATOR
Intervention: Sialic acid concentration in BALF
Number of subjects: 187
Study: 2285641

Group type: EXPERIMENTAL
Intervention: Ketanserin (40 mg twice daily)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg twice daily)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ketanserin plus Captopril (both at specified dosages)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7175506

Group type: EXPERIMENTAL
Intervention: Visual information processing training for approximately seven weeks
Number of subjects: 153

Group type: COMPARATOR
Intervention: Contrast group with small group instruction using regular curriculum materials
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Visual information processing training
Number of subjects: 153
Study: 30854868

Group type: EXPERIMENTAL
Intervention: Half-day wellbeing workshop
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 28905421

Group type: EXPERIMENTAL
Intervention: Exercise consultation every month for 12 months
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 58
Study: 25452050

Group type: EXPERIMENTAL
Intervention: High affirmation
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Low affirmation
Number of subjects: 203

Group type: COMPARATOR
Intervention: Non-smoking image control
Number of subjects: 203

Group type: COMPARATOR
Intervention: Smoking image control
Number of subjects: 203
Study: 23617687

Group type: EXPERIMENTAL
Intervention: Multicomponent pharmaceutical care intervention (patient interview, pharmacotherapy review, execution and follow-up evaluation of a pharmaceutical care plan)
Number of subjects: 674

Group type: EXPERIMENTAL
Intervention: Multicomponent pharmaceutical care intervention
Number of subjects: 674

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 674
Study: 21334200

Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 8873

Group type: EXPERIMENTAL
Intervention: Cytology
Number of subjects: 8873
Study: 19466943

Group type: EXPERIMENTAL
Intervention: Lateralized sextant prostate biopsies
Number of subjects: 1305

Group type: EXPERIMENTAL
Intervention: Initial PSA level
Number of subjects: 1305

Group type: EXPERIMENTAL
Intervention: Prostate volume (Pvol)
Number of subjects: 1305

Group type: COMPARATOR
Intervention: Larger Pvol
Number of subjects: 1305
Study: 17526934

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/day and 80 mg/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 15542205

Group type: EXPERIMENTAL
Intervention: HibCRM197 vaccine (doses > or =1.25 microg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hib-tetanus vaccine (doses > or =1.25 microg)
Number of subjects: 0
Study: 11251436

Group type: EXPERIMENTAL
Intervention: Propofol infusion at 10 mg.s-1
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol infusion at 2 mg.s-1
Number of subjects: 40
Study: 9512842

Group type: EXPERIMENTAL
Intervention: Epidural ketamine 30 mg before induction of anaesthesia
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Epidural ketamine 30 mg 20 min after skin incision
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 7801058

Group type: EXPERIMENTAL
Intervention: NSAID cream (DOLGIT cream)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 3078156

Group type: EXPERIMENTAL
Intervention: Individualized antiarrhythmic therapy (mexiletine or quinidine)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Low-dose amiodarone (200-400 mg/day after a loading phase)
Number of subjects: 238

Group type: COMPARATOR
Intervention: No antiarrhythmic therapy
Number of subjects: 238
Study: 29146139

Group type: EXPERIMENTAL
Intervention: Supplemental nutrition drinks (250 kcal/day) for HIV-positive hemodialysis patients (Group 1)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Supplemental nutrition drinks (250 kcal/day) for HIV-negative hemodialysis patients (Group 2)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Baseline measurements for Group 1
Number of subjects: 23

Group type: COMPARATOR
Intervention: Baseline measurements for Group 2
Number of subjects: 23
Study: 26727338

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 187

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 187
Study: 23887347

Group type: EXPERIMENTAL
Intervention: Thiamine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cobalamin
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Combination of thiamine and cobalamin
Number of subjects: 80

Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Thiamine, Cobalamin, Combination groups
Number of subjects: 80
Study: 22918557

Group type: EXPERIMENTAL
Intervention: High-carbohydrate meal (2,340 kJ, 70 % CHO, 12 % protein)
Number of subjects: 11

Group type: COMPARATOR
Intervention: High-protein meal (35 % CHO, 48 % protein)
Number of subjects: 11